Joslin Diabetes Center/Harvard Medical School, Boston, MA 02215, USA.
Washington University School of Medicine, St. Louis, MO 63110, USA.
J Clin Endocrinol Metab. 2024 Jul 12;109(8):2124-2135. doi: 10.1210/clinem/dgae044.
The role of glycemic control and its variability on the rate of kidney function decline after the onset of diabetic kidney disease (DKD) remains unclear.
The association between baseline glycated hemoglobin (HbA1c) and rates of estimated glomerular filtration rate (eGFR) loss during follow-up was examined by mixed-effects linear regression in 530 individuals with type 1 diabetes and early-to-moderate DKD from the Preventing Early Renal Loss (PERL) trial and 2378 individuals with type 2 diabetes and established DKD from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. The benefit of intensive vs standard glycemic control in slowing eGFR decline was examined in ACCORD. The associations between continuous glucose monitoring-derived short-term glycemic variability indices and rate of eGFR decline were also evaluated in PERL.
A higher baseline HbA1c was associated with a more negative eGFR slope in both PERL and ACCORD (-0.87 and -0.27 mL/min/1.73 m2/year per Hba1c unit increment, P < .0001 and P = .0002, respectively). In both studies, the strength of this association progressively increased with increasing levels of albuminuria (P for interaction <.05). Consistent with this, the benefit of intensive glycemic control on eGFR decline was greater in ACCORD participants with severe rather than moderate albuminuria (+1.13 vs + 0.26 mL/min/1.73 m2/year, P = .01). No independent associations were found in PERL between short-term glycemic variability indices and rate of eGFR decline.
In both type 1 and type 2 diabetes, poor glycemic control is associated with a more rapid rate of glomerular filtration rate decline after DKD onset, especially in persons with severe albuminuria.
糖尿病肾病(DKD)发病后,血糖控制及其变异性对肾功能下降速度的作用仍不清楚。
通过混合效应线性回归分析,检查了 530 例 1 型糖尿病和早期至中度 DKD 的 PERL 试验和 2378 例 2 型糖尿病和既定 DKD 的 ACCORD 试验中个体的基线糖化血红蛋白(HbA1c)与随访期间估计肾小球滤过率(eGFR)损失率之间的关联。在 ACCORD 试验中,检查了强化与标准血糖控制对减缓 eGFR 下降的益处。还在 PERL 试验中评估了连续血糖监测衍生的短期血糖变异性指标与 eGFR 下降率之间的关联。
在 PERL 和 ACCORD 中,较高的基线 HbA1c 与更负的 eGFR 斜率相关(HbA1c 每增加 1 个单位,eGFR 斜率分别为-0.87 和-0.27 mL/min/1.73 m2/year,P<0.0001 和 P=0.0002)。在两项研究中,这种关联的强度随着白蛋白尿水平的升高而逐渐增加(P 交互<.05)。与此一致,在 ACCORD 参与者中,强化血糖控制对 eGFR 下降的益处在严重而非中度白蛋白尿患者中更大(+1.13 与+0.26 mL/min/1.73 m2/year,P=0.01)。在 PERL 中,短期血糖变异性指标与 eGFR 下降率之间未发现独立关联。
在 1 型和 2 型糖尿病中,较差的血糖控制与 DKD 发病后肾小球滤过率下降速度更快相关,尤其是在严重白蛋白尿患者中。